• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多环肽和糖肽类抗生素及其衍生物作为HIV进入抑制剂

Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry.

作者信息

Preobrazhenskaya Maria N, Olsufyeva Eugenia N

机构信息

Gause Institute of New Antibiotics, B. Pirogovskaya 11, Moscow 119021, Russia.

出版信息

Antiviral Res. 2006 Sep;71(2-3):227-36. doi: 10.1016/j.antiviral.2006.04.008. Epub 2006 May 6.

DOI:10.1016/j.antiviral.2006.04.008
PMID:16720053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7114112/
Abstract

Antiviral activity and other biological properties of two groups of polycyclic peptides are discussed. Antibiotics of the complestatin-kistamycin group have a structural motif similar to that of the peptide core of antibacterial antibiotics of the vancomycin-teicoplanin group though no amino acid component in the chloropeptin-kistamicin antibiotics is identical to an amino acid incorporated in the peptide core of the antibiotics of the vancomycin-teicoplanin group. Chloropeptins and the hydrophobic several derivatives of antibacterial antibiotics are inhibitors of HIV and some other viruses. They interfere with the viral (i.e. HIV) entry process. Chemical modifications of natural glycopeptide antibiotics led to the compounds with antiviral properties whereas antibacterial properties were lost. These glycopeptide aglycons derivatives can be envisaged as potential lead compounds for application as microbicides against sexual HIV transmission.

摘要

讨论了两组多环肽的抗病毒活性及其他生物学特性。柔红霉素-奇霉素组抗生素具有与万古霉素-替考拉宁组抗菌抗生素肽核心相似的结构基序,尽管氯肽素-奇霉素抗生素中的氨基酸成分与万古霉素-替考拉宁组抗生素肽核心中所含的氨基酸均不相同。氯肽素及抗菌抗生素的几种疏水衍生物是HIV和其他一些病毒的抑制剂。它们干扰病毒(即HIV)的进入过程。天然糖肽抗生素的化学修饰产生了具有抗病毒特性但失去抗菌特性的化合物。这些糖肽苷元衍生物可被视为用作预防性HIV性传播杀菌剂的潜在先导化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/52810348590a/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/3b2be7f428e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/a6563238abe0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/270848e7fb62/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/447717eaae63/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/45331897d30f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/8200638c38bd/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/52810348590a/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/3b2be7f428e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/a6563238abe0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/270848e7fb62/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/447717eaae63/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/45331897d30f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/8200638c38bd/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e42/7114112/52810348590a/gr7.jpg

相似文献

1
Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry.多环肽和糖肽类抗生素及其衍生物作为HIV进入抑制剂
Antiviral Res. 2006 Sep;71(2-3):227-36. doi: 10.1016/j.antiviral.2006.04.008. Epub 2006 May 6.
2
[Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics].[一系列半合成多环糖肽类抗生素的构效关系]
Bioorg Khim. 2006 Jul-Aug;32(4):339-59.
3
Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics.糖肽类抗生素半合成衍生物的抗逆转录病毒活性。
J Med Chem. 2003 Jun 19;46(13):2755-64. doi: 10.1021/jm0300882.
4
Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin.糖肽类抗生素万古霉素、埃瑞霉素和去氯埃瑞霉素的一系列抗病毒和抗菌苷元衍生物的构效关系研究。
J Med Chem. 2005 Jun 2;48(11):3885-90. doi: 10.1021/jm0500774.
5
Glycopeptide antibiotics and their novel semi-synthetic derivatives.糖肽类抗生素及其新型半合成衍生物。
Curr Pharm Biotechnol. 2011 Aug;12(8):1194-204. doi: 10.2174/138920111796117382.
6
Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.糖肽骨架在糖肽类抗生素疏水衍生物抗菌活性中的作用。
J Med Chem. 2003 Mar 27;46(7):1204-9. doi: 10.1021/jm020320o.
7
Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.苯并恶唑硼酸酯偶联的抗菌糖肽抗生素的合成与抗菌活性研究。
Future Med Chem. 2013 Apr;5(6):641-52. doi: 10.4155/fmc.13.16.
8
Synthesis, Properties, and Mechanism of Action of New Generation of Polycyclic Glycopeptide Antibiotics.新一代多环糖肽类抗生素的合成、性质及作用机制
Curr Top Med Chem. 2017;17(19):2166-2198. doi: 10.2174/1568026617666170130115957.
9
[Chemical modification of glycopeptide antibiotics].[糖肽类抗生素的化学修饰]
Bioorg Khim. 1998 Sep;24(9):644-62.
10
Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.糖肽类抗生素半合成衍生物对猫(猫传染性腹膜炎病毒)和人(严重急性呼吸综合征)冠状病毒的抑制作用
Antiviral Res. 2006 Oct;72(1):20-33. doi: 10.1016/j.antiviral.2006.03.005. Epub 2006 Apr 6.

引用本文的文献

1
Repositioning of Antibiotics in the Treatment of Viral Infections.抗生素在病毒感染治疗中的再定位。
Curr Microbiol. 2024 Oct 26;81(12):427. doi: 10.1007/s00284-024-03948-7.
2
Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors.替考拉宁衍生物可阻断刺突蛋白介导的病毒进入,作为泛 SARS-CoV-2 抑制剂。
Biomed Pharmacother. 2023 Feb;158:114213. doi: 10.1016/j.biopha.2023.114213. Epub 2023 Jan 3.
3
Glycopeptides as Potential Interventions for COVID-19.糖肽类作为新冠病毒病的潜在干预措施

本文引用的文献

1
Emerging drug targets for antiretroviral therapy.抗逆转录病毒疗法的新兴药物靶点
Drugs. 2005;65(13):1747-66. doi: 10.2165/00003495-200565130-00002.
2
Emerging anti-HIV drugs.新型抗艾滋病病毒药物。
Expert Opin Emerg Drugs. 2005 May;10(2):241-73. doi: 10.1517/14728214.10.2.241.
3
Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin.糖肽类抗生素万古霉素、埃瑞霉素和去氯埃瑞霉素的一系列抗病毒和抗菌苷元衍生物的构效关系研究。
Biologics. 2020 Oct 13;14:107-114. doi: 10.2147/BTT.S262705. eCollection 2020.
4
COVID-19 Therapeutic Options Under Investigation.正在研究的COVID-19治疗方案。
Front Pharmacol. 2020 Aug 6;11:1196. doi: 10.3389/fphar.2020.01196. eCollection 2020.
5
Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity.抗菌药物万古霉素的重新设计产生了具有强大抗病毒活性但无抗菌活性的药物。
Pharmaceuticals (Basel). 2020 Jun 29;13(7):139. doi: 10.3390/ph13070139.
6
Battling COVID-19: using old weapons for a new enemy.抗击新冠疫情:用旧武器应对新敌人。
Trop Dis Travel Med Vaccines. 2020 May 20;6:6. doi: 10.1186/s40794-020-00107-1. eCollection 2020.
7
Hydrophobic Derivatives of Glycopeptide Antibiotics as Inhibitors of Protein Kinases.作为蛋白激酶抑制剂的糖肽类抗生素疏水衍生物
Biochemistry (Mosc). 2018 Oct;83(10):1222-1230. doi: 10.1134/S0006297918100073.
8
Fighting viruses with antibiotics: an overlooked path.用抗生素对抗病毒:一条被忽视的途径。
Int J Antimicrob Agents. 2016 Oct;48(4):349-52. doi: 10.1016/j.ijantimicag.2016.07.004. Epub 2016 Aug 5.
9
Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).糖肽类抗生素可有效抑制晚期内体/溶酶体中的组织蛋白酶L,并阻断埃博拉病毒、中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒(SARS-CoV)的进入。
J Biol Chem. 2016 Apr 22;291(17):9218-32. doi: 10.1074/jbc.M116.716100. Epub 2016 Mar 7.
10
Teicoplanin inhibits Ebola pseudovirus infection in cell culture.替考拉宁在细胞培养中抑制埃博拉假病毒感染。
Antiviral Res. 2016 Jan;125:1-7. doi: 10.1016/j.antiviral.2015.11.003. Epub 2015 Nov 14.
J Med Chem. 2005 Jun 2;48(11):3885-90. doi: 10.1021/jm0500774.
4
Isocomplestatin: total synthesis and stereochemical revision.异康普他汀:全合成与立体化学修正
J Am Chem Soc. 2005 May 25;127(20):7334-6. doi: 10.1021/ja051790l.
5
New approaches toward anti-HIV chemotherapy.抗艾滋病病毒化疗的新方法。
J Med Chem. 2005 Mar 10;48(5):1297-313. doi: 10.1021/jm040158k.
6
Total synthesis of anti-HIV agent chloropeptin I.抗艾滋病病毒药物氯肽素I的全合成。
J Am Chem Soc. 2003 Jul 30;125(30):9032-4. doi: 10.1021/ja030249r.
7
Complestatin synthetic studies; the effect of the amino acid configuration on peptide backbone conformation in the common western BCD macrocycle.补体抑制素合成研究;氨基酸构型对常见西方BCD大环中肽主链构象的影响。
Bioorg Med Chem Lett. 2004 Apr 5;14(7):1697-702. doi: 10.1016/j.bmcl.2004.01.056.
8
Complestatin prevents apoptotic cell death: inhibition of a mitochondrial caspase pathway through AKT/PKB activation.制癌他汀可防止凋亡性细胞死亡:通过激活AKT/PKB抑制线粒体半胱天冬酶途径。
Biochem Biophys Res Commun. 2004 Jan 2;313(1):193-204. doi: 10.1016/j.bbrc.2003.11.104.
9
Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA).
Peptides. 2003 Jul;24(7):1093-8. doi: 10.1016/s0196-9781(03)00176-1.
10
Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics.糖肽类抗生素半合成衍生物的抗逆转录病毒活性。
J Med Chem. 2003 Jun 19;46(13):2755-64. doi: 10.1021/jm0300882.